VYVGART Hytrulo
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
73475-3102 -
Package NDC
73475-3102-3 -
Application number
BLA761304 -
SPL ID
a2607d4b-76e8-4004-94c2-190fdc8593fb -
SPL set ID
7104d9e5-9910-47f5-9a93-741ac50f43b6 -
UNII
743QUY4VD8 -
UNII
961YV2O515 -
RxCUI
2639951 -
RxCUI
2639957 -
RxCUI
2712083 -
RxCUI
2712088
What the source publishes
- Labeler
- argenx US
- Active ingredients
- efgartigimod alfa and hyaluronidase (human recombinant)
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
- VYVGART Hytrulo
- efgartigimod alfa and hyaluronidase (human recombinant)
- EFGARTIGIMOD ALFA
- HYALURONIDASE (HUMAN RECOMBINANT)
Complete source data
{
"name": "VYVGART Hytrulo",
"splId": "a2607d4b-76e8-4004-94c2-190fdc8593fb",
"labels": [
{
"setId": "7104d9e5-9910-47f5-9a93-741ac50f43b6",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7104d9e5-9910-47f5-9a93-741ac50f43b6",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7104d9e5-9910-47f5-9a93-741ac50f43b6"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "argenx US",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3102-3) / 5.6 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "73475-3102-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20230620"
}
],
"productId": "73475-3102_a2607d4b-76e8-4004-94c2-190fdc8593fb",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "73475-3102",
"deaSchedule": null,
"genericName": "efgartigimod alfa and hyaluronidase (human recombinant)",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "EFGARTIGIMOD ALFA",
"strength": "180 mg/mL"
},
{
"name": "HYALURONIDASE (HUMAN RECOMBINANT)",
"strength": "2000 U/mL"
}
],
"applicationNumber": "BLA761304",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230620",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175531",
"M0009499",
"N0000194004",
"N0000194005"
],
"unii": [
"743QUY4VD8",
"961YV2O515"
],
"rxcui": [
"2639951",
"2639957",
"2712083",
"2712088"
],
"spl_set_id": [
"7104d9e5-9910-47f5-9a93-741ac50f43b6"
],
"pharm_class_cs": [
"Glycoside Hydrolases [CS]"
],
"pharm_class_epc": [
"Endoglycosidase [EPC]",
"Neonatal Fc Receptor Blocker [EPC]"
],
"pharm_class_moa": [
"Neonatal Fc Receptor Blockers [MoA]"
],
"manufacturer_name": [
"argenx US"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:73475-3102_a2607d4b-76e8-4004-94c2-190fdc8593fb"